Endometriosis is a complex gynaecological disease that remains an enigma for both women and healthcare providers alike; its impact on the hormonal system remains a significant concern. Follicle-stimulating hormone (FSH) is a significant parameter of fertility. Elevated levels of FSH usually reflect a Diminished Ovarian Reserve (DOR), indicating that the body has some problems with egg production.
Although endometriosis is mostly recognised to cause pain and inflammation in the pelvis, its correlation with high levels of FSH is an area of considerable medical research. This article will explore the physiological pathways by which endometriotic lesions, namely chocolate cysts (endometriomas), may harm normal ovarian tissue and interfere with the fine-tuning of the endocrine system. The article will also clarify the relationship between endometriosis and high levels of FSH, how surgical procedures can affect these levels and the consequences of this on fertility and hormone regulation in the long run.
FSH is a hormone produced by the pituitary gland. It stimulates one egg to grow each month in the ovary and be released, and for ovulation to occur. Levels are lower in a normal cycle because the ovaries are quickly sensitive to the stimulation. However, if the ovaries have a low egg supply or "reserve," the pituitary gland releases more FSH to elicit a response. Thus, elevated FSH may indicate reduced ovarian reserve and possible proximity to menopause.
One type of endometriosis is called a chocolate cyst, or endometrioma, in which tissue develops inside the ovary itself. This type of cyst is rather harmful to the ovarian reserve. When an endometrioma becomes large, it applies physical force to the neighbouring healthy ovarian tissue, causing atrophy and destruction of the follicles around the endometrioma.
The biochemical effect of an endometrioma is also very serious. The cyst is filled with stagnant blood and inflammatory mediators, which may be seeping into the normal foci of the ovary. This local inflammation may trigger a process known as follicular recruitment exhaustion, in which the ovary struggles to form follicles in an unfavourable environment, finally exhausting the egg supply. In clinical studies, it is commonly observed that women with large or bilateral endometriomas have an increased likelihood of having a higher basal level of FSH than women with marginal endometriosis.
Ovarian reserve can be defined as the total amount of healthy eggs that are still in the ovaries of a woman. Endometriosis attacks this reserve through multiple pathways. Chronic pelvic inflammation creates a toxic microenvironment that may destroy the DNA of developing oocytes. Inflammatory cytokines and reactive oxygen species in the peritoneal fluid may penetrate the ovarian cortex, causing the increased loss of primordial follicles.
Moreover, the disease often leads to structural changes. The adhesions may entrap the ovaries, distorting their blood supply and restricting the supply of vital nutrients and hormones. This inadequate perfusion can cause follicles to die off faster than they would in a healthy individual. Once the ovarian reserve is severely depleted, the hormonal feedback loop is disrupted, leading to the high FSH levels typically observed in the late stages of the disease.
Although surgery is usually required to relieve the debilitating pain of endometriosis, it is a double-edged sword regarding fertility. The gold standard of treatment is laparoscopic excision of endometriomas (cystectomy); the procedure is associated with an inherent risk to the ovarian reserve.
When a surgeon is removing a cyst wall, it is nearly impossible to prevent the removal of some small piece of healthy, egg-containing tissue in the ovary. Also, thermal damage to the remaining follicles may occur due to the use of cauterisation (electrosurgery) to prevent bleeding. Studies show that the increase in FSH levels while Anti-Müllerian Hormone (AMH) levels decrease is a very common phenomenon in many patients immediately after ovarian surgery. This suggests that the surgery, although useful in relieving pain, might have accelerated depletion of the ovarian reserve and, consequently, increased FSH.
The increase in FSH is not a spontaneous process but the outcome of a complicated biological process. The invasion of endometriosis into the pelvic cavity leads to the production of several inflammatory markers, such as Interleukin-6 (IL-6) and Tumour Necrosis Factor-alpha (TNF-alpha). These markers contribute to:
This cycle of inflammation, destruction, and hormonal counterbalance is the reason why patients with stage III or IV endometriosis often have FSH levels that are indicative of far older patients.
High FSH and endometriosis can only be diagnosed through a multifaceted approach. A single hormone test is hardly enough to provide a complete picture of reproductive health.
In most cases, an elevated FSH level due to reduced ovarian reserve is irreversible. In contrast to other hormonal imbalances that may be caused by stress or a temporary ailment, high FSH caused by physical destruction of ovarian follicles cannot be reversed since the body cannot create new eggs.
However, some fluctuations can occur. When acute inflammation or a temporary exacerbation of the disease may be a partial cause of high FSH, medical management of the inflammation may result in a temporary, small reduction in FSH levels. FSH may also be artificially low in the event of very high oestrogen production, which can occur with some forms of ovarian cysts. Therefore, doctors look at the long-term trend rather than a single data point.
The window for natural conception may be reduced when high FSH is due to endometriosis. Nevertheless, several high-tech reproductive technologies can assist.
Lifestyle changes do not create new eggs or heal damaged ovarian tissue, but they can improve the quality of the remaining eggs and reduce systemic inflammation, which can result in a rise in FSH.
The association between endometriosis and elevated FSH is a crucial factor in determining how endometriosis affects reproductive longevity. Although endometriosis is a disorder of the lining of the pelvis, its capacity to cause chronic inflammation, develop destructive endometriomas and require complicated surgeries directly endangers the ovarian reserve. High FSH is a biological messenger that indicates that the ovaries are not coping with normal follicular development. The FSH and AMH levels of people with endometriosis should be checked regularly, particularly when the patient has undergone surgery or has a history of large cysts.
Timely detection of an increasing pattern in FSH can guide patients and their caregivers to make informed decisions about fertility preservation and treatment, as well as the time of treatment. Although high FSH can be concerning, it does not mean that the dream of having a child is not possible. In contemporary reproductive medicine, there are many avenues, including IVF-based fertility treatment options and donor support, customised to surmount the challenges of low reserve. The most effective way of living with endometriosis is to be proactive in the management of the disease and to have a profound knowledge of the hormonal effects of the disease.